Brian D Lehmann

11PUBLICATIONS
86CO-AUTHORS
Immunogenetics (incl. genetic immunology)Biologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 10, 2025
The Impact of JAK1 Pathogenic Variants and MHC-I Expression on Response to Immune Checkpoint Inhibition in Endometrial Cancer.

Erica V Carballo, Paula Gonzalez-Ericsson, Brian D Lehmann

|Oct 10, 2025
Identification of ligands for E3 ligases with restricted expression using fragment-based methods.

Alex G Waterson, Brian D Lehmann, Zhenwei Lu

|Jul 08, 2025
Phase Ib Trial of Fulvestrant, Palbociclib, and Erdafitinib, a pan-FGFR Tyrosine Kinase Inhibitor, in HR+/HER2- Metastatic Breast Cancer.

Paula I Gonzalez-Ericsson, Nisha Unni, Komal Jhaveri

|Apr 30, 2024
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer.

Elizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson

|Nov 06, 2023
Loss of p73 Expression Contributes to Chronic Obstructive Pulmonary Disease.

Bradley W Richmond, Clayton B Marshall, Jessica B Blackburn

Pageof 2